Fortress Biotech's market cap is currently $44.72M. The company's EPS TTM is $-3.273; its P/E ratio is ―; Fortress Biotech is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.75. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 84.51M	$ 75.74M	$ 68.79M	$ 45.60M	$ 36.63M
Gross Profit	$ 57.85M	$ 44.97M	$ 36.71M	$ 31.00M	$ 26.10M
Operating Income	$ -142.34M	$ -202.26M	$ -179.00M	$ -94.27M	$ -110.82M
EBITDA	$ -133.64M	$ -190.47M	$ -142.25M	$ -87.82M	$ -85.16M
Net Income	$ -60.64M	$ -213.91M	$ -164.83M	$ -102.98M	$ -51.81M
Balance Sheet
Cash & Short-Term Investments	$ 80.93M	$ 178.27M	$ 305.74M	$ 233.35M	$ 136.86M
Total Assets	$ 167.53M	$ 294.30M	$ 396.50M	$ 328.83M	$ 226.42M
Total Debt	$ 88.59M	$ 127.34M	$ 74.98M	$ 89.08M	$ 115.14M
Net Debt	$ 7.67M	$ -50.92M	$ -230.77M	$ -144.28M	$ -21.72M
Total Liabilities	$ 165.94M	$ 244.28M	$ 170.63M	$ 131.84M	$ 153.89M
Stockholders' Equity	$ 22.54M	$ 41.72M	$ 108.67M	$ 100.34M	$ 26.21M
Cash Flow
Free Cash Flow	$ -136.32M	$ -182.46M	$ -132.89M	$ -90.85M	$ -104.36M
Operating Cash Flow	$ -128.22M	$ -179.40M	$ -116.54M	$ -83.68M	$ -94.96M
Investing Cash Flow	$ -2.10M	$ -22.93M	$ 40.51M	$ -7.16M	$ 20.10M
Financing Cash Flow	$ 32.74M	$ 75.32M	$ 148.99M	$ 172.41M	$ 146.71M

Currency in USD

Fortress Biotech Earnings and Revenue History

Income Statement >

Fortress Biotech Debt to Assets

Balance Sheet >

Fortress Biotech Cash Flow

Cash Flow >

Fortress Biotech Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing